ReviewBioengineering (Basel, Switzerland)2024
Use of Hydrogen Peroxide Vapour for Microbiological Disinfection in Hospital Environments: A Review.
Review in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 27 citations in OpenAlex.
- Phage-Antibiotic-Peptide Synergy Overcomes Biofilm-Mediated Multidrug Resistance inAntibiotics (Basel, Switzerland) · 2026Article
- Effectiveness of Hydrogen Peroxide Nebulization Combined with Manual Cleaning in Reducing Surface-Associated Microorganisms in an Indoor Fitness Environment.Microorganisms · 2026Article
- Environmental Disinfection in Long-Term Care Facilities-A Scoping Review.Microorganisms · 2026Review
- Effectiveness of hydrogen peroxide fumigation using an automated fogging system for environmental management in educational institutions.Scientific reports · 2026Article
- A Triple-Modality Peptide-Antibiotic-Phage Therapy Eradicates Multidrug-ResistantbioRxiv : the preprint server for biology · 2026Article
- Reactive oxygen species in health and disease.Molecular biomedicine · 2026Review
- Polyphenols from Byproducts: Their Applications and Health Effects.Antioxidants (Basel, Switzerland) · 2026Review
- Hybrid Mortar Composites Incorporating Oyster Shell Filler and Recycled Fibers from Disposable Masks.Materials (Basel, Switzerland) · 2025Article
- Contamination of hospital surfaces by third-generation cephalosporin-resistant gram-negative bacteria in district hospitals in Mwanza, Tanzania: Urgent need for enhanced infection prevention and control.Infection prevention in practice · 2025Article
- Assessment of dry-fogged hydrogen peroxide as an "untact" room disinfection automation system for rapid terminal decontamination of a single isolation room in a healthcare institution.Antimicrobial resistance and infection control · 2025Article
- Veterinary Clinics as Reservoirs forAntibiotics (Basel, Switzerland) · 2025Review
- Fogging with Hydrogen Peroxide and Hypochlorous Acid: An Option for Disinfection and Reuse of Disposable Isolation Gowns in Medical Practice.Microorganisms · 2025Article
- Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts.Biology · 2025Review
- Beyond quaternary ammonium compounds: Evaluating the harms of non-QAC disinfectant agents in healthcare and industry.GMS hygiene and infection control · 2025Review
- Comparative evaluation of contemporary ultraviolet-C disinfection technologies: UVCeed as a benchmark for smart, portable, and effective pathogen control.GMS hygiene and infection control · 2025Review
- Hydrogen peroxide fogging of isolation gowns: Disinfection efficacy and VOC emissions.PloS one · 2025Article
- Efficacy of Antimicrobial Dry Fog in Improving the Environmental Microbial Burden in an Inpatient Ward.Antibiotics (Basel, Switzerland) · 2024Article
- Method to Generate Chlorine Dioxide Gas In Situ for Sterilization of Automated Incubators.Pathogens (Basel, Switzerland) · 2024Article
- Non-thermal plasma decontamination of microbes: a state of the art.Biotechnology progressReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
Disinfection of nosocomial pathogens in hospitals is crucial to combat healthcare-acquired infections, which can be acquired by patients, visitors and healthcare workers. However, the presence of a wide range of pathogens and biofilms, combined with the indiscriminate use of antibiotics, presents infection control teams in healthcare facilities with ongoing challenges in the selection of biocides and application methods. This necessitates the development of biocides and innovative disinfection methods that overcome the shortcomings of conventional methods. This comprehensive review finds the use of hydrogen peroxide vapour to be a superior alternative to conventional methods. Motivated by observations in previous studies, herein, we provide a comprehensive overview on the utilisation of hydrogen peroxide vapour as a superior high-level disinfection alternative in hospital settings. This review finds hydrogen peroxide vapour to be very close to an ideal disinfectant due to its proven efficacy against a wide range of microorganisms, safety to use, lack of toxicity concerns and good material compatibility. The superiority of hydrogen peroxide vapour was recently demonstrated in the case of decontamination of N95/FFP2 masks for reuse to address the critical shortage caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the COVID-19 pandemic. Despite the significant number of studies demonstrating antimicrobial activity, there remains a need to critically understand the mechanism of action by performing studies that simultaneously measure damage to all bacterial cell components and assess the correlation of this damage with a reduction in viable cell count. This can lead to improvement in antimicrobial efficacy and foster the development of superior approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.